Medincell SA (MEDCL) — Cash Flow-to-Debt Ratio
Medincell SA (MEDCL) has a Cash Flow-to-Debt Ratio of -0.10x as of March 2026, meaning its operating cash flow of €-10.84 Million could theoretically repay 0% of its total liabilities (€104.99 Million) in one year. See MEDCL free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medincell SA Cash Flow-to-Debt Ratio (2016–2026)
Historical debt coverage capacity for Medincell SA across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Medincell SA generate cash.
Annual Cash Flow-to-Debt Ratio for Medincell SA (2016–2026)
Year-by-year debt coverage analysis for Medincell SA. Check Medincell SA (MEDCL) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.23x | €-24.55 Million | €104.99 Million | ▼ -228.3% |
| 2025 | 0.18x | €19.46 Million | €106.82 Million | ▲ +218.9% |
| 2024 | -0.15x | €-11.92 Million | €77.77 Million | ▲ +47.7% |
| 2023 | -0.29x | €-21.00 Million | €71.63 Million | ▲ +20.8% |
| 2022 | -0.37x | €-21.36 Million | €57.67 Million | ▼ -66.9% |
| 2021 | -0.22x | €-12.14 Million | €54.69 Million | ▲ +23.4% |
| 2020 | -0.29x | €-12.54 Million | €43.27 Million | ▲ +42.3% |
| 2019 | -0.50x | €-15.93 Million | €31.74 Million | ▼ -243.2% |
| 2018 | -0.15x | €-5.43 Million | €37.10 Million | ▼ -10.1% |
| 2017 | -0.13x | €-3.39 Million | €25.55 Million | ▼ -2023.0% |
| 2016 | 0.01x | €68.00K | €9.85 Million | — |